RACHEL WISE: Open Payments
NPI 1205524857 · CHATTANOOGA, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$882 in 16 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $306 · 2025 $882
Food & beverage: $882
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 4 | $355 |
| Vanda Pharmaceuticals Inc. | 4 | $180 |
| Axsome Therapeutics, Inc. | 2 | $125 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $110 |
| Supernus Pharmaceuticals, Inc. | 1 | $36 |
| Lundbeck LLC | 2 | $31 |
| E.R. Squibb & Sons, L.L.C. | 1 | $23 |
| Alkermes, Inc. | 1 | $22 |
Products named: AUSTEDO XR, FANAPT, UZEDY, Auvelity, CAPLYTA, Qelbree, REXULTI, COBENFY.
Industry payments across TN — which companies pay providers there.
